USA, Karen Weintraub, Madonna discussed on Daily Coronavirus Update

Automatic TRANSCRIPT

More great vaccine is this week as moderna has said that their vaccine candidate appears to be ninety. Four point five percent effective against covid nineteen. The other good news is that this one can be stored at standard refrigerator temperatures for a month before being used which will make it easier to ship and store karen weintraub health reporter at usa. Today joins us for more. Thanks for joining us. Karen much having some more really good news on the vaccine front last week we heard from this week. We're hearing from dern they're out of cambridge massachusetts and their vaccine candidate they're saying is ninety four point five percent effective against covid nineteen really great news so karen help us run down what we're learning about the moderna vaccine now right. So they're both based on the same technology actually so they're very similar vaccines madonna can be given at a doesn't have to be kept quite as frozen so maybe a little more practical to give especially in rural places but essentially they're very similar vaccines and they're both showing incredible effectiveness. Now these two vaccines as you mentioned. They're both using m. r. n. a. Something that we've never approved before in vaccine. This is pretty new technology and this would be the first thing if approved first pair of vaccines that are using this type of technology. How does that work exactly. So it basically uses the body's own system we make our in as as all the time this trains our body to make a protein that is found on the surface of the virus that causes covid and once our body is used to seize this virus. It's trained to see this protein. It attacks it and response and the good thing you know what happens. Now is a couple of rounds of good news and then right away. We start getting very optimistic about the future. So we have to vaccines. That are coming up. Shaping up really good in. This gives everybody a lot of hope for other ones because we're going to need multiple vaccine candidates to be able to get this across the country across the world. Yes there's no question that we need as many as we can get and assume that several people today who say that. The good news from pfizer. And the durham bodes well for the other vaccines. They're all targeting. The same protein on the surface of the of the virus and so the fact that one and two working suggests that others will as well. Let's talk a little bit more about the effectiveness so pfizer had about forty four thousand people enrolled in their clinical trial and moderna. They had about thirty thousand people and this is also a two-shot protocol. What are we learning. About how many people came down with the virus going through the shots. The way these trials up is they evacuated bunch of people and then wait until they get sick unfortunately because we have so much virus circulating in the us right now. It hasn't taken that long to get a lot of people sick. In both cases. I think five hundred ninety four people who fell ill and madonna had ninety five out of maderna's ninety five five of them had been in a vaccine arm of the trial while the rest had gotten a placebo. So ninety out of ninety five. Get a placebo. Get it and then got the placebo. It only five in the vaccine arm get it. You can statistically conclude at least at this point that it's ninety almost ninety five percent effective. They will look again. This was an interim analysis the final analysis communist at about one hundred sixty infections for both and at that point swimming. These numbers hold. They can be sure that it's ninety more than ninety percent sure that those numbers are real. This vaccine more so than pfizer was involved with operation warp speed. I mean this is being done in conjunction with the us government. Tell us a little bit about that relationship right. The government has been working for years with madonna to develop this platform. This means of of making vaccines quickly for exactly this purpose. Because we don't know. God forbid what's coming next out of the woods somewhere you know we. We tend to be viruses. Tend to come from animals and we can't predict what's coming next so the idea was to create a vaccine that could be deployed quickly in a circumstance. Like this and they still have a few more hoops to go through are going to file for the emergency use authorization. Obviously but there's hurdles with regards to production and a couple of other things as well so They're like visor in particular is likely to go through those very quickly. They have to pass manufacturing to prove that they can manufacture this vaccine safely and its scale five or has said they will have that done by this week. They're also waiting for safety data which is not expected to be a problem but had to wait until two months until half the in the trial at least had got had gone two months after their second infection. If you're gonna have a bad reaction to a vaccine that's very likely to come within the first six weeks of getting the vaccine so the federal government asked him to wait eight weeks to make sure that there weren't problems mysterious problems cropping up at this point. They haven't seen anything but these do have some consequences. You're gonna probably feel lousy for a day or two after getting them muscle pain. You know little fever tired like you have the flu for a day or two so they are not without some side effects but it's a lot better than ending up at a hospital and finally tell us a little bit about the storage of this because you mentioned that you know when we were talking about the pfizer. It has to be sold a really really cold temperatures. This can be stored at more standard refrigerator. Temperatures for up to a month so it could last longer shipping might be a little easier with this and then how many doses are we looking at to be available right away right so both of these. He said require to shots in my arm. It'd be protected. The pfizer vaccine is given three weeks apart. The maderno vaccine is given four weeks apart. And yes the pfizer vaccines to be so cold. I think a colleague discovered that rubber shatters at the temperature of dry ice. Which is the temperature. This has to be kept at in terms of distribution pfizer. Says that they can have fifty million doses by the end of this calendar year. Madeiran estimates about twenty million both expect hundreds of millions of doses available next year. We'll see what happens good news. We're honor way looking forward to that authorization and then we can start getting it out to the country. Just a lot of good news on that front karen weintraub reporter at usa. Today thank very much for joining us. I'm oscar ramirez and this has been reopened in america. Don't forget today's big news stories. You can check me out in the daily podcast every monday through friday so follow us on iheartradio or wherever you get your podcast axios. Today is a new podcast featuring a team of award winning axios journalists and hosted by me nyla buddha. We bring you the latest on the events and trends shaping our world including some of the biggest scoops from washington. Dc this new ten minute. Daily habit helps keep you informed without feeling overwhelmed. Listen to us today. On the iheartradio app.

Coming up next